文献速递腹部技术与安全MR

多中心验证磁共振T2*技术用于胰腺铁定量

Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron.
PubMed 文献 · Eur Radiol · 2018-10-18

本研究在三个主要厂商的十台1.5T磁共振扫描仪上安装多回波T2*序列,对50名健康受试者和45名地中海贫血患者进行胰腺铁评估,并在参考中心复扫。结果显示各中心T2*值与参考中心可比(12.02±10.20 ms vs 11.98±10.47 ms,p=0.808),相关系数0.978,整体ICC为0.995,提示梯度回波T2*技术准确、可重复,可在不同厂商扫描仪间转移。

要点

  • 梯度回波T2*技术可用于胰腺铁定量,且在不同厂商1.5T扫描仪间具有可转移性。
  • 健康受试者胰腺T2*值均高于26 ms,各中心间具有均一性。
  • 各中心T2*值与参考中心高度相关(r=0.978),整体ICC为0.995。

核心结论

  • 梯度回波T2* MRI技术是胰腺铁定量的准确且可重复的方法,可在不同厂商的MRI扫描仪间于多个中心转移使用。

研究设计与样本

  • 多中心验证研究;在三个主要厂商的十台1.5T MRI扫描仪上安装多回波T2*序列;每个中心扫描5名健康受试者(共n=50)和5名地中海贫血患者(共n=45),患者在各中心本地扫描并在1个月内在参考中心复扫;使用先前验证的软件分析T2*图像,全胰T2*值取头、体、尾T2*值的均值。

诊断标准与关键数值

  • 健康受试者T2*值高于26 ms;各中心与参考中心T2*值分别为12.02±10.20 ms vs 11.98±10.47 ms(p=0.808),相关系数0.978(p<0.0001);变异系数(CoV)范围为4.22%至9.77%,所有T2*值不区分中心的CoV为8.55%;各中心组内相关系数(ICC)均极佳,整体ICC为0.995;胰腺铁患者(n=39)平均绝对差异为-0.15±1.38 ms。

临床应用与阅片要点

  • 梯度回波T2* MRI技术可用于胰腺铁定量的多中心应用,并可在不同厂商的1.5T扫描仪间转移;全胰T2*值取头、体、尾均值计算。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the transferability of the magnetic resonance imaging (MRI) multislice multiecho T2* technique for pancreatic iron overload assessment.

METHODS: Multiecho T2* sequences were installed on ten 1.5-T MRI scanners of the three main vendors. Five healthy subjects (n = 50) were scanned at each site. Five patients with thalassemia (n = 45) were scanned locally at each site and were rescanned at the reference site within 1 month. T2* images were analyzed using a previously validated software and the global pancreatic T2* value was calculated as the mean of T2* values over the head, body, and tail.

RESULTS: T2* values of healthy subjects were above 26 ms and showed inter-site homogeneity. The T2* values measured in the MRI sites were comparable to the correspondent values observed in the reference site (12.02 ± 10.20 ms vs 11.98 ± 10.47 ms; p = 0.808), and the correlation coefficient was 0.978 (p < 0.0001). Coefficients of variation (CoVs) ranged from 4.22 to 9.77%, and the CoV for all the T2* values independently from the sites was 8.55%. The intraclass correlation coefficient (ICC) for each MRI site was always excellent and the global ICC was 0.995, independently from the sites. The mean absolute difference in patients with pancreatic iron (n = 39) was -0.15 ± 1.38 ms.

CONCLUSION: The gradient-echo T2* MRI technique is an accurate and reproducible means for the quantification of pancreatic iron and may be transferred among MRI scanners by different vendors in several centers.

KEY POINTS: • The gradient-echo T2* MRI technique is an accurate and reproducible means for the quantification of pancreatic iron. • The gradient-echo T2* MRI technique for the quantification of pancreatic iron may be transferred among MRI scanners by different vendors in several centers. • Pancreatic iron might serve as an early predictor of cardiac siderosis and is the strongest overall predictor of glucose dysregulation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Meloni A, De Marchi D, Pistoia L, et al. Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron. Eur Radiol. 2018. PMID: 30338366. doi:10.1007/s00330-018-5783-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。